NCT05537025: An ongoing trial by Arrowhead Pharmaceuticals
This trial is ongoing. It must report results 3 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05537025 |
|---|---|
| Title | A Phase 1/2a Study Evaluating the Effects of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 30, 2023 |
| Completion date | Sept. 5, 2025 |
| Required reporting date | Sept. 5, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 29, 2026 |
| Days late | None |